PharmaSUG2026paper·US·Real-World Data (RWD) and Real-World Evidence (RWE)PSMATCH: Propensity Score Matching of Clinical Trial Data with External Control Arms RW-367See metadata
PharmaSUG2026paper·US·Real-World Data (RWD) and Real-World Evidence (RWE)Contrast Effects in Curated Observational Data RW-379See metadata
PharmaSUG2026paper·US·Real-World Data (RWD) and Real-World Evidence (RWE)Assessing Quality of Real-World Data Sources RW-384See metadata
PharmaSUG2026paper·US·Real-World Data (RWD) and Real-World Evidence (RWE)Biostatistical Foundations 201: Privacy Preserving Patient Linkage Across Real World Data Sources RW-429See metadata
PharmaSUG2026paper·US·Real-World Data (RWD) and Real-World Evidence (RWE)Operationalizing Real World Data for External Control Arms: An End to End Framework for Rare Disease and Oncology Trials RW-435See metadata
PharmaSUG2026paper·China·Statistics and Analytics (SA)Design and Analysis of a Multi-Frequency PRO Collection Strategy in a Clinical Trial SA-133 ShanghaiSee metadata
PharmaSUG2026paper·China·Statistics and Analytics (SA)ESTICID: a SAS macro for Estimating Clinically Important Difference using an anchor-based approach in longitudinal data SA-138 ShanghaiSee metadata
PharmaSUG2026paper·China·Statistics and Analytics (SA)A Traceable and Reproducible Framework for Oncology Efficacy Data Review Using IMWG Criteria: A BCMA Case Study SA-168 ShanghaiSee metadata
PharmaSUG2026paper·China·Statistics and Analytics (SA)Chronic Graft-versus-Host Disease (cGVHD) efficacy criteria exploration and implementation challenges – based on a first line phase 3 case study SA-176 ShanghaiSee metadata
PharmaSUG2026paper·China·Statistics and Analytics (SA)Handling Missing Data in Analgesia Clinical Trials and Corresponding SAS Implementation SA-191 ShanghaiSee metadata
PharmaSUG2026paper·US·Study Data Integration & AnalysisInsights and Experience Sharing with Patient-Reported Outcome Data Analysis in FDA’s Submission SI-109See metadata
PharmaSUG2026paper·US·Study Data Integration & AnalysisA Statistical Programmer’s Guide to Tipping Point Analysis in SAS SI-227See metadata
PharmaSUG2026paper·US·Study Data Integration & AnalysisFrom Data to Dossier: Lessons from Cross-Company Regulatory Submissions SI-293See metadata
PharmaSUG2026paper·US·Study Data Integration & AnalysisAn Approach for Generating Tumor Biopsy Datasets for Drug Development SI-306See metadata
PharmaSUG2026paper·US·Study Data Integration & AnalysisAlgorithms to align the distribution of follow-up across independently collected cohorts when comparing time to event endpoints using conventional Kaplan Meier and Cox regression methods. SI-348See metadata
PharmaSUG2026paper·US·Study Data Integration & AnalysisFrom Chaos to Consistency: Standardizing External Clinical Data with Excel Power Query SI-373See metadata
PharmaSUG2026paper·US·Study Data Integration & AnalysisHarmonizing History: A Framework for Deriving Line of Therapy in Complex Integrated Summaries. SI-414See metadata
PharmaSUG2026paper·US·Submission Standards for Global Health AuthoritiesStructure for Success: Delivering a Complex, Accelerated NDA with Evolving Scope SS-193See metadata
PharmaSUG2026paper·US·Submission Standards for Global Health AuthoritiesLessons to Guardrails: Operationalizing Early Checks for FDA Submission Readiness SS-209See metadata
PharmaSUG2026paper·US·Submission Standards for Global Health AuthoritiesEfficiency in Action: Automating Bookmarking for CRFs and Other Regulatory Submission Documents SS-243See metadata